CALYPTE BIOMEDICAL CORP Additional Paid in Capital
CALYPTE BIOMEDICAL CORP had Additional Paid in Capital of $159.75 million as of 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2014-06-24
- 2012-12-31: Additional Paid in Capital $159.75M.
- 2012-09-30: Additional Paid in Capital $159.75M.
- 2012-06-30: Additional Paid in Capital $159.75M.
- 2012-03-31: Additional Paid in Capital $159.75M.
| Period end | Additional Paid in Capital |
|---|---|
| 2012-12-31 | $159.75M 10-K · filed 2014-06-24 |
| 2012-09-30 | $159.75M 10-Q · filed 2012-12-31 |
| 2012-06-30 | $159.75M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $159.75M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $159.75M 10-K · filed 2014-06-24 |
| 2011-09-30 | $159.75M 10-Q · filed 2012-01-27 |
| 2011-06-30 | $159.75M 10-Q/A · filed 2011-11-30 |
| 2010-12-31 | $159.75M 10-K · filed 2012-03-22 |